# LeadLens Phase 1 — Amor de Gea Real Context Review

## 1. Repository reconciliation

Initial state: `main` at `526f42abfd5f0c45fb0f14d7da6ce18f3e738fa9`, exactly aligned with `origin/main` (`0 ahead / 0 behind`). Only `.leadlens/source-intelligence.json` and `.leadlens/usage.json` were modified and remain excluded. No staged or untracked files, client files, new migrations or post-`526f42a` commits existed.

| Change | Source | State | Decision | Reason |
|---|---|---|---|---|
| Questionnaire XLSX/PDF/CSV | GPT commits `e6e5572`–`b9ebc95` | Complete | Keep | Reusable, tested, privacy-safe export path. |
| Execution plan and Phase 0 audit | GPT commit `526f42a` | Complete | Keep + update | Correct gates; Phase 1 is now activated by the returned file. |
| Claude implementation | None found | Not present | Nothing to keep/remove | Git, index and worktree contained no Claude commit or code change. |
| Runtime intelligence files | Pre-existing local runtime | Intentional | Exclude | Approved runtime state, unrelated to this sprint. |

No valid prior work was discarded. No history was reset, amended, rebased or force-pushed.

## 2. Client files inspected

- Completed questionnaire: 9 A4 pages, iOS Quartz PDF, no AcroForm, 25 `FreeText` annotations. Fingerprint recorded in code; source PDF is not committed.
- Three supplied product/marketing images inspected. Their fingerprints are recorded, but the images are not committed.
- Images support only `client_marketing_material`; they do not independently verify product benefits, price, dosage, private label, compliance or wholesale availability.
- Respondent information was verified in the source but is not replicated in the Admin review because it is not necessary for the decision layer.

## 3. Ingestion method

Chosen method: a narrowly scoped, curated internal mapping in `lib/intelligence/amor-de-gea-real-context-review.ts`. It maps the exact 17 client-questionnaire keys into a read-only Admin preview with verbatim answers, annotation pages, source fingerprint, evidence status, operational classification, affected routes/accounts, customer-safe impact and reviewer state.

This is smaller and safer than a generic PDF importer. It does not upload the PDF, expose a public URL, write to Supabase, create an accepted context, recalculate theses, call providers or change ranking. Existing Admin entry/acceptance remains the eventual controlled persistence path.

## 4. Completion and evidence state

- 17/17 questions represented.
- 7 answered without a material reservation: products, customization, preliminary price/discount, MOQ, operational constraints, sales-cycle preference and company stage.
- 6 require clarification: margin, attractive account size, capacity, delivery coverage/method, compliance support and measurable pilot objectives.
- 4 missing: private label, current commercial models, preferred commercial models and existing partners/conflicts.
- 13 contain information usable for preliminary intelligence.
- 0 accepted answers; 0 accepted context versions.
- Evidence remains client-stated or client marketing material. Nothing is independently verified.

Original language is preserved. Marketing claims about rest, digestion, energy, dosage and product qualities remain client-provided claims. The questionnaire states that INVIMA, technical sheet, labeling, RUT and chamber documents are active, but no support files/numbers were supplied; compliance is therefore a customer-safe blocker.

## 5. Operational classifications

- **Sufficient to continue:** defined portfolio, customization declaration, preliminary retail/discount context, MOQ, short-cycle preference and company stage.
- **Pending non-blocking:** final margin, VAT, final channel discount, freight allocation and negotiated terms. They do not globally block discovery.
- **Conditioning:** normal/per-SKU capacity, attractive account size, delivery method/economics, glass risk, current/preferred commercial models and measurable objectives.
- **Route-specific blocker:** private label remains unconfirmed and blocks only private-label recommendations.
- **Customer-safe blocker:** unsupported compliance and wellness claims cannot be promoted externally.

## 6. Impact preview — not applied

Likely enabled/strengthened: small retail pilots, specialized natural retail, wellness positioning, gifting/co-branding and hospitality experience hypotheses. Conditioned: distributors, multi-site accounts and procurement-heavy routes. Private label is deprioritized until confirmed; immediate long-cycle accounts conflict with the stated short-cycle preference.

Six-account preview:

- **BioPlaza — strengthen:** concrete product, finished format, MOQ 50 and national coverage declaration. Compliance and channel economics remain open.
- **Distribuidora DAM — uncertain:** scale and customization help, but normal/per-SKU capacity, distributor model, margin and private label remain unresolved.
- **Natural + Mente — strengthen:** wellness positioning, compact premium format and manageable pilot.
- **Tu Tienda Saludable — strengthen:** small initial order and direct-retail compatibility; freight and recurring economics come later.
- **Hotel Spa La Colina — strengthen:** packaging, dropper, gifting and co-branding create plausible amenity/experience uses, not proven demand.
- **Somos Consiente — strengthen:** brand alignment and collaboration become more plausible; repeatable model and buyer path remain unknown.

This sequence is not applied to production ranking and makes no timing or buying-intent claim.

## 7. Pilot Success Contract

Decision: determine which accounts Amor de Gea should work first and how to prepare. Five value dimensions: commercial intelligence, prioritization, pre-meeting preparation, market learning and strategy review.

Indicators cover quality (relevance/rejection/usefulness), action (accounts worked, buyer paths, client-led outreach and conversations), learning (objections, segment response, price/format/channel) and outcomes (opportunities, pilots, orders and sales when available). Review at baseline, after first actions and monthly where useful.

If initial recommendations do not produce sales, LeadLens must inspect whether action occurred, selection quality, buyer path, offer/fit and objections; recalibrate and run another limited search only when justified. It must not simply deliver more leads.

Future priority-account Action Briefs should include rationale, context, visible comparable offering, likely decision area, plausible use case, access path, tailored pitch hypothesis, questions, objections, evidence, unknowns and next action. This sprint does not build that feature or claim exact decision-makers.

## 8. Clarification package

Before context acceptance:

1. Three commercial models to prioritize.
2. Existing clients/partners/accounts to consider or avoid.
3. Three measurable pilot objectives for 90–180 days.
4. Normal, maximum and per-SKU monthly capacity.

Can wait:

1. Whether the preliminary 20%–30% discount includes VAT.
2. Freight, national shipping and glass-breakage handling.
3. Operational private-label availability.
4. Final margin/channel structures.

Request when available: technical sheets, INVIMA support, approved labels, shipping policy, B2B price table and customization/private-label conditions.

## 9. Opportunity Facilitation

Parked in `LEADLENS_NEXT_90_DAYS_EXECUTION_PLAN.md`. Strategically interesting but outside the active product and Phase 1. No UI, data model, contacts, outreach, introductions, commissions, contracts or negotiation workflow was built.

## 10. Security and persistence

The view stays under existing Admin Auth. No client PDF/image is served or committed. No public URL, provider payload, secret or cross-client reuse was added. The preview is deterministic and server-bundled; persistence remains explicitly unaccepted. No migration was created or applied.

## 11. Tests and validation

- New real-context contract: 23 checks.
- Existing client questionnaire: 27 checks.
- Existing pilot questionnaire: 13 checks.
- Existing context review: 50 checks.
- Existing pilot workspace: 48 checks after preserving its evidence invariant.
- Auth regression: 48 checks.
- TypeScript: passed with `npx tsc --noEmit`.
- Production build: passed; 134/134 static pages generated.

## 12. Files modified

- `lib/intelligence/amor-de-gea-real-context-review.ts`
- `lib/intelligence/pilot-workspace.ts`
- `app/admin/intelligence/pilots/[pilotId]/pilot-context-review.tsx`
- `app/admin/intelligence/pilots/[pilotId]/pilot-experience.tsx`
- `app/admin/intelligence/pilots/[pilotId]/workspace.module.css`
- `scripts/fixtures/amor-real-context-review.test.ts`
- `package.json`
- `LEADLENS_NEXT_90_DAYS_EXECUTION_PLAN.md`
- this report and four continuity documents.

## 13. Founder actions and Phase 2 gate

Founder must review the preview, obtain the four priority clarifications and supporting compliance documents, then explicitly authorize entry/submission and acceptance of a real context version. Phase 2 activates only after that reviewed version is accepted. Until then: no thesis recalculation, discovery, ranking change, customer-safe output or final report.
